Filip Scheperjans

scheperjans_filip.jpgConsultant Neurologist,
Clinical Researcher, MD, PhD
Neurocenter, Meilahti Hospitals
Languages: German, Finnish, English
Clinical interests: Parkinson's disease including device assisted therapies for advanced disease such as Deep Brain Stimulation (DBS) and infusion-pump treatments. Gastrointestinal symptoms associated with Parkinson’s disease. Acute neurology and stroke.
Education: MD 2006 University of Düsseldorf, Germany; Specialist in Neurology 2013 University of Helsinki); PhD 2008 University of Düsseldorf, Germany (e-thesis: Quantitative anatomische und neurochemische Charakterisierung des superioren parietalen Kortex des Menschen)
Research: Gastrointestinal symptoms and microbiota in Parkinson’s disease. Treatment and symptom measurement in advanced Parkinson’s disease. Neural growth factors as treatment for Parkinson’s disease. Research funding: Academy of Finland, European Comission, Michael J. Fox Foundation for Parkinson’s Research, Finnish Medical Foundation, Finnish Parkinson Foundation. Most important achievements: First to describe alterations of gut microbiota in neurodegenerative disease. First intracerebral drug infusion in Finland.
2006 Internship, National Hospital for Neurology and Neurosurgery, London, UK
2006 Internship, Mount Sinai School of Medicine, New York City, NY, USA
2006-2007 Researcher, Forschungszentrum Jülich, Germany
2016-2018 Treasurer of the Finnish Neurological Association
2013-2018 Member of the E-health committee of the Finnish Medical Association
2014-2016 Chairman of the ICT-doctors’ subdivision of the Finnish Medical Association
2012-2016 Member of the general assembly of the Finnish Medical Association
Finnish Neurological Association
International Parkinson and Movement Disorder Society
Finnish Medical Association
Finnish Medical Society Duodecim